European Medicines Agency - Regulatory - Regulation of medicines

3 - Specific competencies and capacity to provide export advice



    Description

Name

 

EUNETHYDIS - European Network for Hyperkinetic Disorders

Number of peer reviewed publications in the last 5 years 156 attached list
Number of competitive grants obtained in the last 5 years 4 Network members work together in various groupings. Network members were authors on all pulications
Access to expert groups Yes Various National Child Psychiatry, Neurology, Psychology Bodies (e.g. Royal College of Psychiatrists, American Academy of Child and Adolescent Psychiatry, German Society of Child and Adolescent Psychiatry, German Society of Clinical Neurophysiology etc), European College of Neuropsychopharmacology, British Association of Psychopharmacology, British Medical Association, UK National Institute for Health and Clinical Excellence.
Capacity to answer external scientific questions Yes Members are frequently called on by industry, regulators, government bodies to answer scientific questions about a wide range of trial related and non-trial related subjects. Members have worked in both industry and academic settings.
Site feasibility Yes Initially most studies were single site or industry sponsored where this was generally conducted by external bodies. However, with the recent EU awards the network has developed the skills to assess sites for suitability for a given trial. Standardised procedures are being developed across these studies.
Participant recruitment Yes All sites have a wealth of experience in recruiting and monitoring. recruitment.
Budget calculation for studies Yes see 3.5